.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Chubb
Baxter
Moodys
Dow
Merck
Harvard Business School
McKesson
Mallinckrodt

Generated: July 23, 2017

DrugPatentWatch Database Preview

HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% Drug Profile

« Back to Dashboard

Which patents cover Heparin Sodium 10,000 Units In Dextrose 5%, and when can generic versions of Heparin Sodium 10,000 Units In Dextrose 5% launch?

Heparin Sodium 10,000 Units In Dextrose 5% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% is heparin sodium. There are seventy-seven drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the heparin sodium profile page.

Summary for Tradename: HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Clinical Trials: see list6,142
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5%
heparin sodium
INJECTABLE;INJECTION018911-006Jan 30, 1985DISCNNoNo► Subscribe► Subscribe
Hospira
HEPARIN SODIUM 10,000 UNITS IN DEXTROSE 5% IN PLASTIC CONTAINER
heparin sodium
INJECTABLE;INJECTION019339-003Mar 27, 1985APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Dow
Fish and Richardson
UBS
Queensland Health
Moodys
Baxter
Harvard Business School
Fuji
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot